Funding
← Back to your selection

Hillhouse Investment

Activity from announced rounds

Activity in this selectionUnited States
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$107M
2 disclosed · full round size, not this investor’s share

By stage

Series A2

By primary sector

Biotech1
Healthtech1

By country

United States2

Rounds

2 in this selection
Axoft

Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders

$55MSeries A
Role not disclosed
Third Arc Bio

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+
Role not disclosed